TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
75,972
|
107,896
|
95,731 |
| Financial expenses |
70
|
0
|
1 |
| Earnings before taxes |
7,549
|
12,343
|
13,845 |
| EBITDA |
5,826
|
11,184
|
12,885 |
| Total assets |
47,010
|
48,258
|
43,419 |
| Current assets |
37,019
|
40,357
|
38,903 |
| Current liabilities |
7,333
|
11,286
|
14,873 |
| Equity capital |
37,301
|
34,807
|
27,064 |
| - share capital |
104
|
102
|
96 |
| Employees (average) |
14
|
13
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.3%
|
72.1%
|
62.3% |
| Turnover per employee |
5,427
|
8,300
|
7,364 |
| Profit as a percentage of turnover |
9.9%
|
11.4%
|
14.5% |
| Return on assets (ROA) |
16.2%
|
25.6%
|
31.9% |
| Current ratio |
504.8%
|
357.6%
|
261.6% |
| Return on equity (ROE) |
20.2%
|
35.5%
|
51.2% |
| Change turnover |
-33,870
|
5,372
|
29,162 |
| Change turnover % |
-31%
|
5%
|
44% |
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
8%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.